05004nam 22010335 450 991078996150332120210204234722.01-280-11677-397866135210640-520-95242-110.1525/9780520952423(CKB)2670000000161477(EBL)877896(OCoLC)782926070(SSID)ssj0000621889(PQKBManifestationID)11383830(PQKBTitleCode)TC0000621889(PQKBWorkID)10617468(PQKB)11128975(DE-B1597)519595(OCoLC)1109202610(DE-B1597)9780520952423(MiAaPQ)EBC877896(EXLCZ)99267000000016147720200424h20112011 fg engur||#||||||||txtccrPills, Power, and Policy The Struggle for Drug Reform in Cold War America and Its Consequences /Dominique TobbellBerkeley, CA :University of California Press,[2011]©20111 online resource (311 p.)California/Milbank Books on Health and the Public ;23Description based upon print version of record.0-520-27113-0 Front matter --Contents --Foreword --Acknowledgments --Introduction: Pharmaceutical Politics, Then and Now --1. Knowledgeable Relations: The Building of a Pharmaceutical Research Network --2. Workforce Relations: The Invention of the Pharmaceutical Postdoctoral Fellowship --3. Professional Relations: Crafting the Public Image of the Health Care Team --4. Cold War Alliances: Kefauver's Bid for Pharmaceutical Reform --5. Expert Alliances: The Creation of the Drug Research Board --6. Generic Alliances and the Backlash against Regulatory Reform --Epilogue --Notes --Bibliography --IndexSince the 1950's, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation. Pills, Power, and Policy offers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic researchers, the book provides essential historical context for understanding how corporate interests came to dominate American health care policy after World War II.California/Milbank Books on Health and the PublicDrug Industry -- history -- United StatesDrugs -- Research -- United States -- History -- 20th centuryEconomics, Pharmaceutical -- United StatesHistory, 20th Century -- United StatesPharmaceutical industry - United States - History - 20th centuryDrugsResearchHistory20th centuryUnited StatesPharmaceutical industryHistory20th centuryUnited StatesEconomicsHistory, Modern 1601-HumanitiesIndustryHealth Care Economics and OrganizationsTechnology, Industry, and AgricultureHealth CareDrug IndustryEconomics, PharmaceuticalHistory, 20th CenturyHistoryNorth AmericaAmericasGeographic LocationsUnited StatesDrug Industry -- history -- United States.Drugs -- Research -- United States -- History -- 20th century.Economics, Pharmaceutical -- United States.History, 20th Century -- United States.Pharmaceutical industry - United States - History - 20th century.DrugsResearchHistoryPharmaceutical industryHistoryEconomicsHistory, Modern 1601-HumanitiesIndustryHealth Care Economics and OrganizationsTechnology, Industry, and AgricultureHealth CareDrug IndustryEconomics, PharmaceuticalHistory, 20th CenturyHistory338.4/76151338.476151Tobbell Dominique A.1978-,authttp://id.loc.gov/vocabulary/relators/aut1505883DE-B1597DE-B1597BOOK9910789961503321Pills, Power, and Policy3735834UNINA